The uptake of glucose is mediated mainly by the sodium-glucose cotransporter, SGLT1. Previous studies using quantitative PCR showed that SGLT1 mRNA was induced in the yolk sac and in the small intestine prior to hatch. However, PCR analysis did not allow for the localization of cells expressing SGLT1 mRNA. The objective of this study was to use in situ hybridization to identify cells in the yolk sac and small intestine that expressed SGLT1 mRNA during the transition from late embryogenesis to early post-hatch. Expression of SGLT1 mRNA in yolk sac epithelial cells was low from embryonic d 11 to 17, peaked at embryonic d 19, and declined at day of hatch. In the small intestine, cells expressing SGLT1 mRNA were present not only along the intestinal villi but also in the crypts. There was greater expression of SGLT1 mRNA in the intestinal epithelial cells that line the villus than in the olfactomedin 4-expressing stem cells located in the crypts. The latter result suggests that stem cells have the ability to import glucose. Expression of SGLT1 mRNA in the intestine increased from embryonic d 19 to day of hatch and then maintained a high level of expression from d 1 to d 7 post-hatch. For both the yolk sac and small intestine, the temporal pattern of SGLT1 mRNA expression detected by in situ hybridization was consistent with the pattern revealed by PCR. 
INTRODUCTION
From the pre-hatch to the post-hatch stage, the chick transitions from the uptake of nutrients from lipid-rich yolk by the yolk sac (YS) to uptake of nutrients from carbohydrate and protein-rich feed by the small intestine (Moran, 2007) . The YS develops from the embryonic gut and gradually forms the epithelial endoderm and vascular mesoderm that covers the yolk (Mobbs and McMillan, 1979; Bauer et al., 2013) . The small intestine contains villi and the YS contains villus-like structures that project into the yolk or intestinal lumen to increase the surface area for enhancing nutrient uptake (Holdsworth and Wilson, 1967; Mobbs and McMillan, 1981; Noble and Cocchi, 1990) . Thus, the YS and intestine share not only structural features but also functional properties.
The YS and intestine play essential roles in the uptake of nutrients. The YS is a multifunctional organ that provides the essential functions of several organs that have not yet fully developed. These functions include nutrient absorption, production of blood factors, C 2018 Poultry Science Association Inc. Received May 7, 2018. Accepted July 12, 2018. 1 Corresponding author: ewong@vt.edu and synthesis of blood cells (Yadgary et al., 2014) . Cells of the YS express several nutrient transporters that are also expressed by cells of the small intestine, such as amino acid, peptide, fat, and monosaccharide transporters (Yadgary et al. 2011 (Yadgary et al. , 2014 Speier et al., 2012; Bauer et al., 2013; Zhang and Wong, 2017) . During late embryogenesis, as the YS starts to degrade, amniotic fluid is swallowed by the embryo and some yolk is transferred through the yolk stalk into the small intestine to provide nutrients that are absorbed in the small intestine (Uni et al., 2003; reviewed in Uni and Ferket, 2004) . During the late embryonic and post-hatch periods, the small intestine expresses a wide variety of nutrient transporters (Gilbert et al., 2007; Zeng et al., 2011; Miska et al., 2014 Miska et al., , 2015 .
Glucose is the major energy substrate for animals to produce ATP through aerobic oxidation. The sodium glucose transporter SGLT1 (SLC5A1) is the major glucose transporter that is located at the brush border membrane of enterocytes (Garriga et al., 1999; Barfull et al., 2002; Wright, 2013) , which are derived from intestinal stem cells that are marked by olfactomedin 4 (Olfm4) and leucine-rich repeat containing G-protein coupled receptor 5 (Lgr5) in both mammals and chickens (Carulli et al., 2014; Zhang and Wong, 2018) . The driving force for transport of glucose from the intestinal 984 lumen into the enterocyte by SGLT1 is the co-transport of Na + down a sodium gradient, which is maintained by the Na + -K + ATPase on the basolateral membrane (Drozdowski and Thomson, 2006) . During embryogenesis, the glucose concentration in the yolk is low and the chick embryo mainly relies on lipid oxidation to produce energy (Speake et al., 1998) . Near the end of incubation (e.g., embryonic day (e) 19), the concentration of glucose in the yolk increases due to gluconeogenesis and glycogenolysis occurring in the YS and anaerobic oxidation of glucose becomes the dominant pathway for generating energy for the embryo (Yadgary et al., 2010; Yadgary and Uni, 2012) .
Studies using quantitative PCR showed that there is an increase in SGLT1 mRNA in the YS and small intestine. In the YS, SGLT1 mRNA showed low expression from e11 to e17, peak expression at e19 or e20, which corresponded to the increase in glucose concentration in the yolk, followed by a decrease at e21 as the YS degraded (Yadgary et al., 2011; Speier et al., 2012) . In the small intestine, there is an increase in SGLT1 mRNA from e19 to day of hatch, and then high-level expression post-hatch (Gilbert et al., 2007; Li et al., 2008; Speier et al., 2012) . The objective of this study was to identify cells in the YS and small intestine that express SGLT1 mRNA by in situ hybridization.
MATERIALS AND METHODS

Sample Collection and Preparation
Cobb 500 eggs were obtained from a local hatchery and incubated at 37
• C with 50% relative humidity. Hatched chicks were reared together in a large pen with ad libitum access to water and feed. The feed was a standard corn-soybean starter diet that was formulated to meet NRC requirements. All animal procedures were approved by the Institutional Animal Care and Use Committee at Virginia Tech. At embryonic d 11, 13, 15, 17, and 19, embryos were removed and killed by decapitation. YS samples (0.5 cm × 0.5 cm) were collected from the area vasculosa and rinsed in cold phosphate buffered saline (PBS). At e19, day of hatch (doh), d 1, d 4, and d 7 post-hatch, chicks were killed by cervical dislocation and small intestinal samples were collected and separated into duodenum, jejunum, and ileum and then rinsed with cold PBS. Both YS and intestinal samples were fixed in 10% neutral buffered formalin (Thermo Fisher Scientific, Waltham, MA) for 24 h and stored in 70% ethanol until embedding in paraffin (Histo-Scientific Research Labs Inc., Mount Jackson, VA).
In Situ Hybridization
The formalin-fixed paraffin-embedded tissues were cut into 5 μm sections using a microtome and mounted on slides. The tissue sections were deparaffinized in xylene and rinsed in absolute ethanol. In situ hybridization was performed using the RNAscope procedure (Advanced Cell Diagnostics, Newark, CA; Wang et al., 2012) . Probes to the protein coding regions of Gallus gallus SGLT1 (NM 001293240.1) and Olfm4 (NM 001040463.1) were custom synthesized. Probes to the bacterial gene dapB were supplied by ACD and used as a negative control. The RNAscope 2.5 HD Detection kit (BROWN) was used for detection of SGLT1 mRNA in the small intestine, while the RNAscope 2.5 HD Detection kit (RED) was used for detection in the YS. The red chromogen in the RNAscope 2.5 HD Detection kit (RED) has the additional property of being fluorescent and thus is better for detecting low level expression. Because we expected low-level SGLT1 mRNA expression in the YS and high-level SGLT1 mRNA expression in the intestine, we used the red chromogen for the YS and the brown chromogen for the intestine. Tissue sections were first counterstained with 50% Gill #2 hematoxylin (Sigma Aldrich, St. Louis, MO) and then treated with 0.02% ammonia water to turn the stain from purple to blue. A drop of VectaMount mounting medium (Vector Laboratories, Inc. Burlingame, CA) was placed on the tissue, and a coverslip was gently placed on top. Images were captured with a Nikon Eclipse 80i microscope equipped with a DS-Ri1 digital camera.
Image and Statistical Analysis
Three replicate YS samples were processed for in situ hybridization. Because each red dot represents an SGLT1 mRNA molecule, mRNA expression can be quantified. Three representative images (×400) of each YS sample were selected, and the number of red dots was enumerated. The area of each YS sample that appeared on the image was measured by using Image J software developed by the National Institutes of Health (https://imagej.nih.gov/ij/). The number of dots was divided by the YS sample area (mm 2 ) to calculate the density of SGLT1 mRNA/YS area. Data were analyzed using one-way ANOVA (α = 0.05) using JMP Statistical Discovery Software v10.0 (SAS Institute Inc., Cary, NC). Significant differences were further evaluated with Tukey's test.
RESULTS AND DISCUSSION
Cells Expressing SGLT1 mRNA in the Yolk Sac SGLT1 mRNA was detected in the YS epithelial cells from e11 to doh, with the greatest expression at e19 ( Figure 1A) . The negative control with the bacterial gene dapB showed no staining ( Figure 1A ). SGLT1 mRNA expression was quantified by counting the number of dots, which represent SGLT1 mRNA molecules, per area of YS. Abundance of SGLT1 mRNA was similar between e11 and e17, peaked at e19, and then declined at doh ( Figure 1B) , which is consistent with the staining pattern for SGLT1 mRNA shown Figure 1 . Expression of SGLT1 mRNA in chicken yolk sac from embryonic d 11 to day of hatch. (A) Yolk sac samples were fixed in formalin, embedded in paraffin, and sectioned. SGLT1 mRNA was detected by in situ hybridization using the RNAscope 2.5 HD Detection kit (RED) at embryonic d 11 (e11), 13 (e13), 15 (e15), 17, (e17), 19 (e19), and day of hatch (doh) and is shown in the top 6 panels. The negative control dapB (bottom panel) was performed on yolk sac at e19, which was the age that showed the highest level of SGLT1 mRNA expression. The tissues were counterstained with hematoxylin. Images were captured using ×200 magnification. The scale bars represent 0.1 mm. (B) Average number of red dots (each dot represents a SGLT1 mRNA) per area (mm 2 ) of yolk sac. Data were obtained from images at ×400 magnification and quantified using ImageJ software. Bars with different letters (A-C) are significantly different (P < 0.05). Intestinal segments were fixed in formalin, embedded in paraffin, and sectioned. SGLT1 mRNA was detected by in situ hybridization using the RNAscope 2.5 HD Detection kit (BROWN). Each brown dot represents an SGLT1 mRNA molecule. The red arrows indicate the location of putative progenitor transit amplifying cells. Tissues were counterstained with hematoxylin. Images were captured using ×200 magnification. The scale bars represent 0.1 mm.
in Figure 1A . During the period of greatest SGLT1 mRNA expression (e19) and to a lesser extent at e17, SGLT1 mRNA staining appeared clustered around the nuclei of some cells, rather than dispersed throughout the cytoplasm. This may depict cells that are in the process of actively transcribing SGLT1 premRNA, which has not yet been transported into the cytoplasm.
The in situ hybridization images were consistent with the results reported for qPCR analysis, which showed an increase in SGLT1 mRNA in the YS from e17 to e19/e20 and then a decrease at e21 (Yadgary et al., 2011; Speier et al., 2012 Speier et al., , 2014 . The increase in SGLT1 mRNA and presumably SGLT1 transporter activity coincided with an increase in the concentration of glucose in the yolk. During embryogenesis, the amount of carbohydrate in the yolk increases, with glucose in the yolk increasing from 20 mg at e11 to 60 mg at e19 (Yadgary et al., 2010 . This is partly due to the increase in mRNA expression for enzymes in the YS that are involved in gluconeogenesis and glycogenolysis . Together these processes release glucose into the yolk, which can then be taken up by SGLT1 expressed in the YS epithelial cells.
Cells Expressing SGLT1 mRNA in the Small Intestine
The distribution of cells expressing SGLT1 mRNA in the duodenum, jejunum, and ileum from e19 to d 7 post-hatch is shown in Figure 2 . SGLT1 mRNA was expressed in not only the enterocytes lining the villi but also cells in the crypt. SGLT1 mRNA expression in the enterocytes was low at e19, increased to doh, and then maintained a high level of expression from d 1 to d 7 post-hatch. SGLT1 mRNA expression in the enterocytes was qualitatively similar between duodenum, jejunum, and ileum. These temporal results were consistent with the published qPCR results showing an increase in SGLT1 mRNA in chicken intestine from late embryogenesis until early post-hatch (Gilbert et al., 2007; Speier et al., 2012) .
To better visualize staining for SGLT1 mRNA in cells, a higher magnification of the ends of villi is shown in Figure 3 , along with the negative control. SGLT1 mRNA was expressed in the epithelial cells lining the villi and did not appear to be expressed in the goblet cells, which are revealed as unstained cells. The negative control using the bacterial gene dapB showed no staining.
Staining for SGLT1 mRNA was also present in cells in the crypts, but at a lower level compared to the enterocytes along the villi. Similar to the enterocytes, there was an increase in staining for SGLT1 mRNA in the crypts with age, although not as dramatic as in the enterocytes of the villi (Figure 2) . Because the crypt contains putative stem cells that express Olfm4 in chickens (Zhang and Wong, 2018) , serial sections from jejunum at d 4 were stained for SGLT1 and Olfm4 mRNA and are shown at higher magnification in Figure 4 . Enterocytes lining the villi and cells in the crypt expressed SGLT1 mRNA, whereas only cells in the crypt expressed Olfm4 mRNA. The expression of SGLT1 and Olfm4 mRNA in crypt cells suggests that glucose is an important nutrient for proliferation of stem cells. Zhou et al. (2018) showed that the addition of glucose to mouse intestinal epithelial crypts increased crypt proliferation and glycolysis. A number of studies have examined the localization of SGLT1 mRNA expression using in situ hybridization and of SGLT1 protein using immunocytochemistry in different species with varying results. SGLT1 mRNA was expressed in the epithelial cells along the villus but not in the crypts of the small intestine of rabbits (Hwang et al., 1991) and mice (Yoshikawa et al., 2011) . Consistent with the mRNA results, SGLT1 protein was detected only in the brush border membrane of the enterocytes along the villus and not in the crypt cells in the small intestine of chickens (Barfull et al., 2002) and rabbits (Hwang et al., 1991) . Using quantitative PCR, Yang et al. (2011) showed that SGLT1 mRNA abundance was 30 to 35% lower in crypt cells compared to villus cells in the small intestine of neonatal pigs. The increased sensitivities of qPCR and the RNAscope assays may explain why SGLT1 mRNA was detectable in the crypt cells.
Using a glucose protectable phlorizin binding assay, measured the number of glucose transporters along the mouse intestinal villus-crypt axis. They reported high expression of glucose transporters from the villus tip to midvillus and low expression in the intestinal crypts. In response to a high carbohydrate diet, there was an increased number of transporters in the cells along the villus and in the crypts. further showed that the increase in the number of glucose transporters first appeared in the crypts. This suggests that the crypt cells, which are likely the stem cells, are capable of sensing the change in glucose concentration and inducing the expression of glucose transporters before the enterocytes migrate up the villus.
At doh, there was a population of cells located just above the crypts that showed reduced staining for SGLT1 mRNA (indicated by the red arrows in Figure 2) compared with the more intense staining in the epithelial cells in the rest of the villus. This reduced staining pattern, which was most obvious in the duodenum, was similar to that observed for the peptide transporter PepT1 mRNA (Zhang and Wong, 2017) . These weakly staining cells are likely progenitor transit amplifying cells, which are a population of cells that originate from stem cells in the crypt, but have not become a differentiated cell type (Carulli et al., 2014) .
In conclusion, SGLT1 mRNA was expressed in the epithelial cells of the YS, with low expression between e11 and e17, peak expression at e19, and low expression at doh. In the small intestine, SGLT1 mRNA was expressed in cells along the intestinal villus-crypt axis. There was upregulation of SGLT1 mRNA in epithelial cells from e19 to doh, which was then maintained at a high level of expression from d 1 to d 7 post-hatch. Cells in the crypt, which are presumably stem cells, also expressed SGLT1 mRNA, which showed that these cells can import glucose.
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